1. Home
  2. PTGX vs WULF Comparison

PTGX vs WULF Comparison

Compare PTGX & WULF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PTGX
  • WULF
  • Stock Information
  • Founded
  • PTGX 2006
  • WULF 1952
  • Country
  • PTGX United States
  • WULF United States
  • Employees
  • PTGX N/A
  • WULF N/A
  • Industry
  • PTGX Biotechnology: Pharmaceutical Preparations
  • WULF EDP Services
  • Sector
  • PTGX Health Care
  • WULF Technology
  • Exchange
  • PTGX Nasdaq
  • WULF Nasdaq
  • Market Cap
  • PTGX 2.8B
  • WULF 1.6B
  • IPO Year
  • PTGX 2016
  • WULF 1995
  • Fundamental
  • Price
  • PTGX $47.91
  • WULF $6.95
  • Analyst Decision
  • PTGX Strong Buy
  • WULF Strong Buy
  • Analyst Count
  • PTGX 7
  • WULF 8
  • Target Price
  • PTGX $52.83
  • WULF $6.03
  • AVG Volume (30 Days)
  • PTGX 450.1K
  • WULF 26.6M
  • Earning Date
  • PTGX 11-08-2024
  • WULF 11-12-2024
  • Dividend Yield
  • PTGX N/A
  • WULF N/A
  • EPS Growth
  • PTGX N/A
  • WULF N/A
  • EPS
  • PTGX 2.75
  • WULF N/A
  • Revenue
  • PTGX $319,120,000.00
  • WULF $120,247,000.00
  • Revenue This Year
  • PTGX $400.33
  • WULF $129.08
  • Revenue Next Year
  • PTGX N/A
  • WULF $87.70
  • P/E Ratio
  • PTGX $17.54
  • WULF N/A
  • Revenue Growth
  • PTGX 125.73
  • WULF 197.49
  • 52 Week Low
  • PTGX $13.76
  • WULF $0.89
  • 52 Week High
  • PTGX $48.89
  • WULF $7.28
  • Technical
  • Relative Strength Index (RSI)
  • PTGX 60.40
  • WULF 69.41
  • Support Level
  • PTGX $45.33
  • WULF $6.41
  • Resistance Level
  • PTGX $48.89
  • WULF $7.28
  • Average True Range (ATR)
  • PTGX 1.28
  • WULF 0.55
  • MACD
  • PTGX 0.11
  • WULF 0.17
  • Stochastic Oscillator
  • PTGX 77.11
  • WULF 82.04

About PTGX Protagonist Therapeutics Inc.

Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.

About WULF TeraWulf Inc.

TeraWulf Inc is a digital asset technology company that is engaged in digital infrastructure and sustainable energy development. The company's primary focus is supporting environmentally conscious bitcoin mining operations by developing and operating facilities within the United States. The company's bitcoin mining facilities are powered by clean, affordable, and reliable energy sources. The company's primary source of revenue stems from the mining of bitcoin conducted at the company's mining facility sites. Additionally, the company occasionally generates revenue through the provision of miner hosting services to third-party entities.

Share on Social Networks: